A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer
Clinical trial NCT04094519 · COMPLETED
Trial details
- NCT number
- NCT04094519
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-27
- Primary completion
- 2020-12-27
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.